Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Anika Therapeutics
(NQ:
ANIK
)
25.90
+0.11 (+0.43%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Anika Therapeutics
< Previous
1
2
Next >
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
April 18, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 08, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
February 27, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting
February 13, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
November 28, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Participate in Upcoming Investor Conferences
November 07, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
October 10, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting
September 19, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 15, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
September 12, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs
August 17, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
July 20, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting
July 12, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone
May 30, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023
April 19, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Enters Into Cooperation Agreement with Caligan Partners
April 13, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference
April 12, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA
April 03, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Files Preliminary Proxy Statement
March 27, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
March 15, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Highlights Products in High Growth Segments of Joint Preservation during the 2023 AAOS Annual Meeting
March 08, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Participate in the Canaccord Genuity Musculoskeletal Conference
February 28, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023
February 21, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Issues Statement
February 21, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Announces First Surgeries Performed Using the New RevoMotion™ Reverse Shoulder Arthroplasty System and Commences Limited Market Release in the United States
February 13, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika’s Cingal® Successfully Achieves Primary Endpoint in Third Phase III Study
November 01, 2022
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
October 25, 2022
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Receives the ACE Award for Cutting-Edge Innovation for Tactoset® Injectable Bone Substitute from the American Orthopedic Society for Sports Medicine
July 27, 2022
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Sidoti's Summer Small Cap Virtual Conference
June 14, 2022
NEW YORK, NY / ACCESSWIRE / June 14, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day Summer Small Cap Virtual Conference taking place Wednesday and...
From
Sidoti & Company, LLC
Via
AccessWire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.